We further identified that a high expression of LEPR significantly correlated with worse prognosis of breast cancer patients, which suggesting that the rs4655555 variant may affect breast cancer risk and development through regulating the expression of LEPR, and subsequently prognosis. Here, LEPR is linked to breast carcinoma.